News
13d
Zacks Investment Research on MSNIceCure Medical Stock Dips Despite Positive ICESECRET Study ResultsIceCure Medical ICCM presented interim results from its ICESECRET kidney cancer cryoablation study at the European ...
Hosted on MSN2mon
How To Prevent And Treat Kidney CancerAn individual who has kidney cancer and who is unable to undergo a surgical procedure to remove their malignancy may need to have cryoablation as part of their treatment. Numerous health ...
The SINGLE SHOT CHAMPION study increases momentum for PFA as a first-line option for pulmonary vein isolation, say experts.
Cryoablation: a medical procedure that uses extreme cold to destroy abnormal or diseased tissue. Huang currently works as a part of the Temerty Faculty of Medicine at the University of Toronto, in ...
Halton Healthcare is the first regional hospital to offer renal (kidney) cryoablation, a minimally invasive procedure that targets kidney tumours with precision while minimizing recovery time.
IceCure Medical (ICCM) announced that interim results from the Company’s ICESECRET study of cryoablation for patients with small renal masses ...
ICCM reports strong kidney cancer cryoablation study results, showcasing 88.7% recurrence-free rates and reinforcing its position in cryoablation technology. IceCure Medical Ltd. (Nasdaq ...
Pulsed field ablation using Boston Scientific Corp.’s Farapulse system was non-inferior and even superior, slightly, to Medtronic plc’s Artic Front Advance cardiac cryoablation system in treating ...
Cryoablation of Breast Cancer ... in tumor destruction in benign and cancerous lesions, including breast, kidney, lung, and liver. ProSense® enhances patient and provider value by accelerating ...
"With over 50 granted patents for cryoablation systems and cryoprobes ... with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe ...
IceCure Medical ICCM presented interim results from its ICESECRET kidney cancer cryoablation study at the European Association of Urology Conference in Spain. The study reported an 88.7% ...
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results